These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10328507)

  • 1. Acute cholestasis during long-term treatment with fluvastatin in a nephrotic patient.
    Gascón A; Zabala S; Iglesias E
    Nephrol Dial Transplant; 1999 Apr; 14(4):1038. PubMed ID: 10328507
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluvastatin for lowering cholesterol.
    Med Lett Drugs Ther; 1994 May; 36(923):45-6. PubMed ID: 8177137
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and safety of fluvastatin in hyperlipidemic protease inhibitor-treated HIV-infected patients.
    Doser N; Kübli S; Telenti A; Marzolini C; Chave JP; Feihl F; Buclin T; Pannatier A; Darioli R; Nicod P; Waeber B; Mooser V
    AIDS; 2002 Sep; 16(14):1982-3. PubMed ID: 12351967
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of metabolic disorders with fluvastatin after renal transplantation.
    Podder H; Gerõ L; Földes K; Szabó J; Lazar N; Járay J
    Transplant Proc; 1997; 29(1-2):216-9. PubMed ID: 9122968
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluvastatin in renal transplantation.
    Hadjigavriel M; Kyriakides G
    Transplant Proc; 1997 Nov; 29(7):3050. PubMed ID: 9365661
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term event monitoring study of fluvastatin in Japanese patients with hypercholesterolemia: Efficacy and incidence of cardiac and other events in elderly patients (≥ 65 years old).
    Itakura H; Nakaya N; Kusunoki T; Shimizu N; Hirai S; Mochizuki S; Ishikawa T
    J Cardiol; 2011 Jan; 57(1):77-88. PubMed ID: 21067897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of fluvastatin in hypercholesterolemia in renal transplant recipients.
    Ghods AJ; Milanian I; Arghani H; Ghadiri G
    Transplant Proc; 1995 Oct; 27(5):2579-80. PubMed ID: 7482835
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluvastatin.
    Lawrence JM; Reckless JP
    Expert Opin Pharmacother; 2002 Nov; 3(11):1631-41. PubMed ID: 12437496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and lipid-lowering effect of fluvastatin in hypercholesterolaemic patients on maintenance haemodialysis.
    Ichimaru N; Takahara S; Moriyama T; Kondo M; Nonomura N; Tanaka T; Wang JD; Imai E; Okuyama A; Kondo Y
    J Int Med Res; 2004; 32(1):45-52. PubMed ID: 14997705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal lupus-like syndrome and ARDS induced by fluvastatin.
    Sridhar MK; Abdulla A
    Lancet; 1998 Jul; 352(9122):114. PubMed ID: 9672281
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypotensive effect of an inhibitor of cholesterol synthesis (fluvastatin). A pilot study].
    Abetel G; Poget PN; Bonnabry JP
    Schweiz Med Wochenschr; 1998 Feb; 128(7):272-7. PubMed ID: 9540154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvastatin exposure during pregnancy.
    Seguin J; Samuels P
    Obstet Gynecol; 1999 May; 93(5 Pt 2):847. PubMed ID: 10912423
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of efficacy and safety assessment of fluvastatin in patients <65 years versus > or =65 years of age.
    Bruckert E; Verpilleux MP; Dejager S; Isaacsohn J
    Am J Cardiol; 2005 Oct; 96(8):1142-8. PubMed ID: 16214453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluvastatin-induced dermatomyositis].
    Thual N; Penven K; Chevallier JM; Dompmartin A; Leroy D
    Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 1):996-9. PubMed ID: 16446645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of fluvastatin in subjects with renal impairment and nephrotic syndrome.
    Appel-Dingemanse S; Smith T; Merz M
    J Clin Pharmacol; 2002 Mar; 42(3):312-8. PubMed ID: 11865968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of long acting fluvastatin on parameters of lipid metabolism in patients with type 2 diabetes and combined hyperlipidemia].
    Kozlov SG; Liakishev AA; Titov VN; Naumov VG
    Kardiologiia; 2004; 44(10):60-3. PubMed ID: 15477793
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of fluvastatin in women with primary hypercholesterolaemia.
    Peters TK; Muratti EN; Mehra M
    Drugs; 1994; 47 Suppl 2():64-72. PubMed ID: 7517836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvastatin and cancer.
    Mascitelli L; Pezzetta F
    Int J Clin Pract; 2007 Jan; 61(1):168; author reply 168-9. PubMed ID: 17229191
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.
    Samuelsson O; Attman PO; Knight-Gibson C; Mulec H; Weiss L; Alaupovic P
    Am J Kidney Dis; 2002 Jan; 39(1):67-75. PubMed ID: 11774104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin toxicity: a situation that mimics viral hepatitis.
    Cokça F; Ozkan S; Nergisoglu G; Memikoglu O; Azap A
    Int J Clin Pharmacol Ther; 2005 Nov; 43(11):543-5. PubMed ID: 16300170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.